AIM TO DRIVE CLINICAL DISCOVERY THROUGH OPTIMIZED MATHEMATICAL NEURO-ONCOLOGY RESPONSE METRICS BY CONNECTING PATIENT-SPECIFIC TREATMENT RESPONSE TO PATIENT-SPECIFIC BENEFIT.

PI: Kristin R. Swanson, Ph.D.
Co-Director, Precision NeuroTherapeutics Innovation Program
Director, Mathematical NeuroOncology Lab
Professor and Vice Chair of Research, Neurosurgery
Mayo Clinic

Close Menu